Follow us on:
Issue Alert
Issue Alert
BoraBiologics_CoverSponsor_0526_650x90

May 2026 Issue is Now Live!

 

Explore the Full List of Features Now >>
Top News

Breaking News
Promotions & Moves

AdvanCell Names New CTO and CSO, Expanding Executive Leadership Team

The company’s previous Chief Scientific Officer will transition to the role of Chief Isotope Development Officer.

SPONSOR

Commercial Geography is a Strategic Variable

Inspection history, trade exposure, and geographic alignment now define commercial readiness. Read the May cover feature.

Breaking News
Collaborations & Alliances

Shilpa Medicare, Gate2Brain Partner to Advance First-in-Class Brain Cancer Therapy

Shilpa becomes a strategic shareholder and partner in Gate2Brain’s lead program.

Breaking News

J&J Agrees to Acquire Firefly Bio for $1B

Firefly Bio’s capabilities in emerging modalities, including the Firelink DAC platform, complement Johnson & Johnson’s existing expertise in antibody engineering.

BoraBiologics_CoverSponsor_0526_650x250

Breaking News

Gilead Sciences, Lakefront Biotherapeutics Acquire Ouro Medicines

The acquisition adds gamgertamig to Gilead’s inflammation portfolio and will be the foundation of Lakefront’s clinical development pipeline.

Breaking News

WuXi Biologics Tops Out Modular Drug Product Facility in Singapore

Once operational, the facility will be the company's key drug product facility designed to meet the latest and most stringent requirements for international markets.

SPONSOR

Advancing Sterile Liquid Development: Enabling Integrated Solutions for Small Molecules and Biologics

In this Pharma Matters Q&A, Anshul Gupte, PhD, RAC Drugs, VP of Pharmaceutical Development at PCI Pharma Services, provides updates on the expansions in Bedford and León, Spain, and talks about the importance and advantages of being able to offer services across multiple modalities.

Breaking News
Collaborations & Alliances

Sanofi Inks Five-Year Pact to License Owkin’s AI Scientist K Pro for Next-Gen Biopharma Agents

The two companies have collaborated on other fronts since 2021.

Breaking News
Financial News

Haga Bioscience Closes $2.3M Funding Round to Commercialize Spatial Biology Tech

The company hopes to bridge spatial biomarker discovery and clinical translation.

Breaking News
Collaborations & Alliances

Massive Bio, Optellum Partner on Early Detection, Clinical Trial Access for Lung Cancer

A first-of-its-kind integration of a clinically validated cancer prediction AI is at the heart of the partnership.

Featured Resources

Solution Content Centers SPOTLIGHT

Praxis Packaging Solutions

Contract packaging demands flexibility, efficiency, and control. At Praxis, we deliver all three through the innovative, cost effective application of manual labor and the skillful use of automated and custom packaging equipment. We've been doing so for about a quarter century. Our OTC/Rx pharmaceutical, consumer products, and medical device customers choose us for four reasons: a relentless focus on compliance, astonishing speed-to-market, unyielding accountability, and significant category experience. At Praxis, we don't just deliver innovative, turnkey packaging solutions. We provide them while exceeding our customers' expectations, while managing their critical deadlines, and while upholding rigorous regulatory and quality standards. You could call it agility; we call it Managed Rapid Response, and here at Praxis, it's at the heart of what we do. Upholding standards is so deeply engrained at Praxis that, since the company was formed, we've had exactly zero recalls.

 

Solution Center SPOTLIGHT

Simtra BioPharma Solutions

As a premier, independently owned CDMO with over 65+ years of sterile injectable manufacturing experience, Simtra BioPharma Solutions (Simtra) offers world-class cGMP sterile fill/finish, technical expertise, quality service, and a uniquely collaborative approach. Pharmaceutical and biotech companies partner with Simtra when they face formulation challenges, clinical supply hurdles, surges in demand due to market fluctuations, or risk mitigation concerns. Our teams are driven to offer clients tailored and versatile solutions to help them bring their products to market.